Prof. Dr. med. Michael Pinkawa
Chief Physician of the Clinic for Radiotherapy and Radiation Oncology | Medical Director
+49 228 5306-101
'+49 228 5306-102
Research
June 13, 2024
Regression of all untreated lesions in multifocal low-grade meningioma following fractionated stereotactic radiotherapy—abscopal effect or spontaneous regression?
Abscopal effects have been reported predominantly in metastatic cancers, indicating a radiographic response in a lesion that has not been included in the radiotherapy target volume.
October 3, 2023
Application of a Radiopaque Viscous Hydrogel Spacer for Prostate Cancer Radiation Therapy: A Prospective Phase 2 Study
The aim of this study was to evaluate the application of a radiopaque viscous spacer (RVS) for prostate cancer radiation therapy (RT), including injection procedure, toxicity, treatment planning, image guidance, and imaging results up to 12 months after RT
October 11, 2023
A pooled long-term follow-up after radiotherapy for prostate cancer with and without a rectal hydrogel spacer: impact of hydrogel on decline in sexual quality of life
The purpose of this study was to analyze the impact of prostate rectal spacers on sexual quality of life (QOL) following external beam radiation therapy (RT).
December 2022
Focal injection of a radiopaque viscous spacer before focal brachytherapy as re-irradiation for locally recurrent prostate cancer
Close vicinity of the target volume and a sensitive organ may prevent an effective radiotherapy/brachytherapy. A liquid hydrogel spacer cannot be placed well focally in specific small areas or fatty tissue.
June 2022
Permanent interstitial brachytherapy for prostate cancer implementing neoadjuvant prostatic artery embolization
Indication for permanent interstitial brachytherapy (PIB) can be limited by prostate volume, commonly decreased using neoadjuvant hormonal therapy.
March 9, 2022
Long-Term Comparative Study on the Local Tumour Control of Different Ablation Technologies in Primary and Secondary Liver Malignancies
To evaluate local tumour control (LTC) by local ablation techniques (LAT) in liver malignancies. Materials and methods: In patients treated with LAT between January 2013 and October 2020 target lesions were characterised by histology, dimensions in three spatial axes, volume, vascularisation and challenging (CL) location
July 2021
Radiotherapy in nodal oligorecurrent prostate cancer
The current article encompasses a literature review and recommendations for radiotherapy in nodal oligorecurrent prostate cancer.
July 2021
Salvage stereotactic body radiotherapy (SBRT) for intraprostatic relapse after prostate cancer radiotherapy: An ESTRO ACROP Delphi consensus
Between 30% and 47% of patients treated with definitive radiotherapy (RT) for prostate cancer are at risk of intraprostatic recurrence during follow-up
September 2020
Long-term follow-up after radiotherapy for prostate cancer with and without rectal hydrogel spacer: a pooled prospective evaluation of bowel-associated quality of life
To evaluate the long-term bowel-associated quality of life (QOL) in men after radiotherapy (RT) for prostate cancer with and without the use of rectal hydrogel spacer.
December 2019
ESTRO ACROP consensus guideline on the use of image guided radiation therapy for localized prostate cancer
Use of image-guided radiation therapy (IGRT) helps to account for daily prostate position changes during radiation therapy for prostate cancer. However, guidelines for the use of IGRT are scarce
Dr. Michael Pinkawa's complete list of publications
Below you will find a complete list of all publications and research work by Dr. Michael Pinkawa
Your message
E-mail to: Prof. Dr. med. Michael Pinkawa
*Mandatory fields